Study explores racial differences in gastric cancer immunotherapy outcomes
Advanced gastric cancer remains one of the deadliest malignancies, with a 5-year overall survival rate below 10%. In…
Immunotherapy plus chemotherapy improves outcomes in stage III dMMR colon cancer
A new study from researchers at the Alliance for Clinical Trials in Oncology (Alliance) shows that patients with…
Combination therapy may help overcome barrier in early-stage prostate cancer treatment
A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy…
Early-life immune system differences drive childhood eczema risk
A team of researchers at the Icahn School of Medicine at Mount Sinai, Weill Cornell Medicine, and other…
Scientists discover why some cancer treatments stop working
A quiet problem has followed cancer immunotherapy for years. The immune system can be taught to fight, then…
MHC class II marks stronger immune response and longer survival in ovarian cancer
A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond…
Cholesterol transporter ABCA1 boosts macrophage-driven cancer immunity
In recent years, cancer researchers have made major breakthroughs by using the body’s immune system to fight cancer.…
‘Plug-and-play’ system could improve cancer immunotherapy
Share this Article You are free to share this article under the Attribution 4.0 International license. Researchers have…
Dinutuximab beta plus chemotherapy shrinks neuroblastoma tumors in children
Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has…
Triaptosis-based therapeutic innovations could offer renewed hope for cancer patients
Cancer remains one of the most critical global public health challenges, exerting profound social, economic, and clinical burdens…
Single-cell study reveals how HPV shapes immune landscape in penile cancer
Although penile cancer represents less than 1% of male malignancies, it carries substantial physical and psychological burden, with…
Researchers achieve long-term remission with novel T cell therapies for HPV-related cancers
Researchers from Rutgers Cancer Institute, New Jersey’s only National Cancer Institute (NCI) – designated Comprehensive Cancer Center, and…